颖泰生物
(920819)
| 流通市值：32.35亿 | | | 总市值：32.73亿 |
| 流通股本：12.12亿 | | | 总股本：12.26亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 903,084,204.65 | 937,424,499.12 | 1,020,979,931.88 | 1,144,662,654.68 |
| 应收票据及应收账款 | 1,256,069,319.65 | 1,266,064,360.4 | 1,292,880,129.36 | 1,289,216,835.31 |
| 应收账款 | 1,256,069,319.65 | 1,266,064,360.4 | 1,292,880,129.36 | 1,289,216,835.31 |
| 应收款项融资 | 129,719,559.43 | 204,405,057.23 | 160,683,740.7 | 150,957,234.88 |
| 预付款项 | 47,002,230.87 | 48,310,059.68 | 50,709,500.34 | 39,872,787 |
| 其他应收款合计 | 66,944,896.5 | 86,146,373.37 | 98,664,274.84 | 138,415,540.33 |
| 其中:应收利息 | 884,000 | 3,001,249.67 | 4,693,694.12 | 8,357,162.74 |
| 存货 | 1,293,394,848.08 | 1,364,620,872.44 | 1,214,187,045.01 | 1,334,641,060.08 |
| 合同资产 | 9,412,841.32 | 9,330,966.82 | 7,793,306.16 | 8,249,695.18 |
| 其他流动资产 | 175,602,175.66 | 191,889,230.3 | 186,871,048.41 | 226,264,042.14 |
| 流动资产合计 | 3,881,230,076.16 | 4,108,191,419.36 | 4,032,768,976.7 | 4,332,279,849.6 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,525,338,681.98 | 1,582,210,489.5 | 1,581,343,770.55 | 1,594,217,542.27 |
| 投资性房地产 | 106,848,174.59 | 108,013,272.23 | 109,178,369.79 | 110,343,467.43 |
| 固定资产 | 3,254,417,629.07 | 3,294,839,249.97 | 3,387,355,531.67 | 3,475,688,820.59 |
| 在建工程 | 575,187,915.67 | 603,461,452.39 | 582,049,236.89 | 540,761,947.21 |
| 使用权资产 | 29,612,978.95 | 30,169,308.52 | 30,725,638.09 | 31,281,967.66 |
| 无形资产 | 649,646,208.85 | 657,697,156.4 | 665,470,071.53 | 672,416,280.88 |
| 商誉 | 324,276,895.66 | 324,276,895.66 | 324,276,895.66 | 324,276,895.66 |
| 长期待摊费用 | 20,132,445.52 | 16,832,046.42 | 18,118,725.81 | 19,310,540.5 |
| 递延所得税资产 | 217,559,430.03 | 210,413,527.91 | 205,074,803.68 | 201,534,031.94 |
| 其他非流动资产 | 121,506,769.59 | 108,811,931.83 | 107,376,328.01 | 93,100,852.22 |
| 非流动资产合计 | 6,824,527,129.91 | 6,936,725,330.83 | 7,010,969,371.68 | 7,062,932,346.36 |
| 资产总计 | 10,705,757,206.07 | 11,044,916,750.19 | 11,043,738,348.38 | 11,395,212,195.96 |
| 流动负债: | | | | |
| 短期借款 | 2,209,359,095.91 | 2,286,935,508.11 | 2,322,797,384.8 | 2,391,616,247.57 |
| 交易性金融负债 | 8,019,784.86 | 7,940,809.61 | 3,127,642.63 | 1,370.4 |
| 应付票据及应付账款 | 1,375,965,757.45 | 1,498,819,136.08 | 1,437,337,451.98 | 1,558,120,610.35 |
| 其中：应付票据 | 802,226,549.38 | 726,637,714.64 | 690,393,650.05 | 837,490,931.97 |
| 应付账款 | 573,739,208.07 | 772,181,421.44 | 746,943,801.93 | 720,629,678.38 |
| 预收款项 | 4,797,231.92 | 4,413,612.16 | 4,682,006.99 | 4,716,628.67 |
| 合同负债 | 189,635,811.2 | 42,741,403.49 | 80,341,993.51 | 124,143,138.63 |
| 应付职工薪酬 | 64,016,718.39 | 58,261,626.81 | 56,152,316.87 | 112,315,290.11 |
| 应交税费 | 27,868,011.69 | 24,027,351.48 | 33,325,424.29 | 47,345,707.66 |
| 其他应付款合计 | 136,637,600.2 | 135,821,550.95 | 132,292,125.01 | 139,583,321.89 |
| 一年内到期的非流动负债 | 1,003,577,525.11 | 1,105,140,171.98 | 1,118,375,982.01 | 1,191,238,423.02 |
| 其他流动负债 | 8,903,312.94 | 2,879,051.46 | 5,642,969.54 | 7,684,389.91 |
| 流动负债合计 | 5,028,780,849.67 | 5,166,980,222.13 | 5,194,075,297.63 | 5,576,765,128.21 |
| 非流动负债: | | | | |
| 长期借款 | 845,523,796.09 | 946,056,619.89 | 907,960,731.86 | 847,487,501.39 |
| 租赁负债 | 17,634,831.47 | 18,867,523.06 | 22,965,730.76 | 18,454,634.47 |
| 长期应付款 | 4,647,931.75 | 4,669,771.75 | 4,691,611.75 | 4,668,901.75 |
| 递延收益 | 127,581,835.35 | 127,299,808.5 | 129,874,737.46 | 132,449,666.42 |
| 递延所得税负债 | 44,083,768.11 | 46,322,720.57 | 46,517,085.11 | 46,661,560.32 |
| 非流动负债合计 | 1,039,472,162.77 | 1,143,216,443.77 | 1,112,009,896.94 | 1,049,722,264.35 |
| 负债合计 | 6,068,253,012.44 | 6,310,196,665.9 | 6,306,085,194.57 | 6,626,487,392.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 |
| 资本公积 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 |
| 其他综合收益 | -154,373,759.05 | -138,327,002.06 | -115,575,171.95 | -101,822,722.39 |
| 专项储备 | 11,442,606.23 | 13,945,784.96 | 11,479,635.05 | 8,286,758.32 |
| 盈余公积 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 |
| 未分配利润 | 349,444,493.72 | 425,686,066.32 | 400,224,085.83 | 419,970,824.71 |
| 归属于母公司股东权益合计 | 4,664,634,143.12 | 4,759,425,651.44 | 4,754,249,351.15 | 4,784,555,662.86 |
| 少数股东权益 | -27,129,949.49 | -24,705,567.15 | -16,596,197.34 | -15,830,859.46 |
| 股东权益合计 | 4,637,504,193.63 | 4,734,720,084.29 | 4,737,653,153.81 | 4,768,724,803.4 |
| 负债和股东权益合计 | 10,705,757,206.07 | 11,044,916,750.19 | 11,043,738,348.38 | 11,395,212,195.96 |
| 公告日期 | 2026-10-23 | 2026-08-14 | 2026-04-24 | 2026-04-16 |
| 审计意见(境内) | | | | 标准无保留意见 |